Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Nickel accumulation in lung tissues is associated with increased risk of p53 mutation in lung cancer patients.

Chiou YH, Wong RH, Chao MR, Chen CY, Liou SH, Lee H.

Environ Mol Mutagen. 2014 Oct;55(8):624-32. doi: 10.1002/em.21867. Epub 2014 Apr 8.

PMID:
24711049
2.

Nickel may contribute to EGFR mutation and synergistically promotes tumor invasion in EGFR-mutated lung cancer via nickel-induced microRNA-21 expression.

Chiou YH, Liou SH, Wong RH, Chen CY, Lee H.

Toxicol Lett. 2015 Aug 19;237(1):46-54. doi: 10.1016/j.toxlet.2015.05.019. Epub 2015 May 27.

PMID:
26026961
3.

p53 mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer.

Husgafvel-Pursiainen K, Boffetta P, Kannio A, Nyberg F, Pershagen G, Mukeria A, Constantinescu V, Fortes C, Benhamou S.

Cancer Res. 2000 Jun 1;60(11):2906-11.

4.

Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.

Gao WM, Romkes M, Day RD, Siegfried JM, Luketich JD, Mady HH, Melhem MF, Keohavong P.

Carcinogenesis. 2003 Oct;24(10):1671-6. Epub 2003 Jul 4.

PMID:
12844488
5.

High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.

Wang YC, Chen CY, Chen SK, Cherng SH, Ho WL, Lee H.

Cancer Res. 1998 Jan 15;58(2):328-33.

6.

Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.

Gealy R, Zhang L, Siegfried JM, Luketich JD, Keohavong P.

Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 1):297-302. Erratum in: Cancer Epidemiol Biomarkers Prev 2001 Dec;10(12):1309.

7.

Polymorphisms in DNA repair genes XPD and XRCC1 and p53 mutations in lung carcinomas of never-smokers.

Gao WM, Romkes M, Siegfried JM, Luketich JD, Keohavong P.

Mol Carcinog. 2006 Nov;45(11):828-32.

PMID:
16865671
8.

p53 Mutations in lung cancer associated with residential radon exposure.

Yngveson A, Williams C, Hjerpe A, Lundeberg J, Söderkvist P, Pershagen G.

Cancer Epidemiol Biomarkers Prev. 1999 May;8(5):433-8.

9.

Association between smoking and p53 mutation in lung cancer: a meta-analysis.

Liu X, Lin XJ, Wang CP, Yan KK, Zhao LY, An WX, Liu XD.

Clin Oncol (R Coll Radiol). 2014 Jan;26(1):18-24. doi: 10.1016/j.clon.2013.09.003. Epub 2013 Oct 11. Erratum in: Clin Oncol (R Coll Radiol). 2014 Jun;26(6):359.

PMID:
24126199
10.

p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity.

Wu X, Zhao H, Amos CI, Shete S, Makan N, Hong WK, Kadlubar FF, Spitz MR.

J Natl Cancer Inst. 2002 May 1;94(9):681-90.

PMID:
11983757
11.

Accumulation of chromium and nickel metals in lung tumors from lung cancer patients in Taiwan.

Kuo CY, Wong RH, Lin JY, Lai JC, Lee H.

J Toxicol Environ Health A. 2006 Jul;69(14):1337-44.

PMID:
16760140
12.

Analysis of aromatic DNA adducts and 7,8-dihydro-8-oxo- 2'-deoxyguanosine in lymphocyte DNA from a case-control study of lung cancer involving minority populations.

Vulimiri SV, Wu X, Baer-Dubowska W, de Andrade M, Detry M, Spitz MR, DiGiovanni J.

Mol Carcinog. 2000 Jan;27(1):34-46. Erratum in: Mol Carcinog 2000 Apr;27(4):330.

PMID:
10642435
13.

Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study.

Wei Q, Cheng L, Amos CI, Wang LE, Guo Z, Hong WK, Spitz MR.

J Natl Cancer Inst. 2000 Nov 1;92(21):1764-72.

PMID:
11058619
14.

Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.

Wu JY, Wang J, Lai JC, Cheng YW, Yeh KT, Wu TC, Chen CY, Lee H.

Ann Surg Oncol. 2008 Nov;15(11):3272-7. doi: 10.1245/s10434-008-0078-9. Epub 2008 Aug 20.

PMID:
18712569
15.

Exon 8 mutation of p53 gene associated with nodal metastasis in non-small-cell lung cancer.

Lee LN, Shew JY, Sheu JC, Lee YC, Lee WC, Fang MT, Chang HF, Yu CJ, Yang PC, Luh KT.

Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 1):1667-71.

PMID:
7952630
16.

Rapid method for determination of DNA repair capacity in human peripheral blood lymphocytes amongst smokers.

El-Zein RA, Monroy CM, Cortes A, Spitz MR, Greisinger A, Etzel CJ.

BMC Cancer. 2010 Aug 18;10:439. doi: 10.1186/1471-2407-10-439.

17.

p53 and K-ras mutations in lung cancers from former and never-smoking women.

Vähäkangas KH, Bennett WP, Castrén K, Welsh JA, Khan MA, Blömeke B, Alavanja MC, Harris CC.

Cancer Res. 2001 Jun 1;61(11):4350-6.

18.

Distribution of p53 and K-ras mutations in human lung cancer tissues.

Gao HG, Chen JK, Stewart J, Song B, Rayappa C, Whong WZ, Ong T.

Carcinogenesis. 1997 Mar;18(3):473-8.

PMID:
9067544
19.

Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.

Huang C, Taki T, Adachi M, Konishi T, Higashiyama M, Miyake M.

Oncogene. 1998 May 14;16(19):2469-77.

20.

Influence of common XPD and XRCC1 variant alleles on p53 mutations in lung tumors.

Hou SM, Ryk C, Kannio A, Angelini S, Fält S, Nyberg F, Husgafvel-Pursiainen K.

Environ Mol Mutagen. 2003;41(1):37-42.

PMID:
12552590

Supplemental Content

Support Center